SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(PROCTOR S)
 

Sökning: WFRF:(PROCTOR S) > (2015-2019) > World Workshop on O...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004322naa a2200637 4500
001oai:gup.ub.gu.se/223145
003SwePub
008240528s2015 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2231452 URI
024a https://doi.org/10.1007/s00784-015-1488-22 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Villa, A.4 aut
2451 0a World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment
264 c 2015-05-22
264 1b Springer Science and Business Media LLC,c 2015
520 a Objectives Medication-induced salivary gland dysfunction (MISGD) causes significant morbidity resulting in decreased quality of life. This systematic review assessed the literature on the prevalence, diagnosis, treatment, and prevention of MISGD. Materials and methods Electronic databases were searched for articles related to MISGD through June 2013. Four independent reviewers extracted information regarding study design, study population, interventions, outcomes, and conclusions for each article. Only papers with acceptable degree of relevance, quality of methodology, and strength of evidence were retained for further analysis. Results There were limited data on the epidemiology of MISGD. Furthermore, various methods were used to assess salivary flow rate or xerostomia. Preventive and therapeutic strategies included substitution of medications, oral, or systemic therapy with sialogogues, use of saliva substitutes or of electro-stimulating devices. Although there are promising approaches to improve salivary gland function, most studies are characterized by small numbers and heterogeneous methods. Conclusions Physicians and dentists should identify the medications associated with xerostomia and salivary gland dysfunction through a thorough medical history. Preferably, health care providers should measure the unstimulated and stimulated whole salivary flow rates of all their patients so that these values can be used as a baseline to rate the complaints of patients who subsequently claim to experience xerostomia or salivary gland dysfunction as well as the possibilities of effectively treating this condition. Clinical relevance MISGD remains a major burden for the population. This systematic review provides a contemporary in-depth description of the diagnosis and treatment of MISGD.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Odontologi0 (SwePub)302162 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Dentistry0 (SwePub)302162 hsv//eng
653 a Xerostomia
653 a Saliva
653 a Medications
653 a Salivary gland dysfunction
653 a PRIMARY SJOGRENS-SYNDROME
653 a DRUG-INDUCED XEROSTOMIA
653 a RAT PAROTID-GLAND
653 a INDUCED DRY MOUTH
653 a FLOW-RATES
653 a DOUBLE-BLIND
653 a PILOCARPINE TREATMENT
653 a CLINICAL-TRIAL
653 a PSYCHIATRIC-PATIENTS
653 a SUBJECTIVE REPORTS
653 a Dentistry
653 a Oral Surgery & Medicine
700a Wolff, A.4 aut
700a Aframian, D.4 aut
700a Vissink, A.4 aut
700a Ekström, Jörgen,d 1944u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi,Institute of Neuroscience and Physiology, Department of Pharmacology4 aut0 (Swepub:gu)xeksjo
700a Proctor, G.4 aut
700a McGowan, R.4 aut
700a Narayana, N.4 aut
700a Aliko, A.4 aut
700a Sia, Y. W.4 aut
700a Joshi, R. K.4 aut
700a Jensen, S. B.4 aut
700a Kerr, A. R.4 aut
700a Dawes, C.4 aut
700a Pedersen, A. M. L.4 aut
710a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi4 org
773t Clinical Oral Investigationsd : Springer Science and Business Media LLCg 19:7, s. 1563-1580q 19:7<1563-1580x 1432-6981x 1436-3771
8564 8u https://gup.ub.gu.se/publication/223145
8564 8u https://doi.org/10.1007/s00784-015-1488-2

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy